Delivery Order SPE2DB20D3101-SPE2DB23FRMS5

Award Date 5/26/23
Potential Completion Date 5/30/23
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,921.41 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,741.44 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,871.68 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.40 Firm Fixed Price Delivery Order contract is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of September 15, 2023 and was awarded on September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,726.04 firm fixed-price delivery order is for the supply of Spiriva Respimat 1.25 MCG inhalation medication. The contract has an ultimate completion date of May 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $3,229.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,005.49 Firm Fixed Price Delivery Order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The award has an ultimate completion date of February 5, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,608.93, is a delivery order for the medical product SPIRIVA 18MCG 30S. The contract has a firm fixed price and an ultimate completion date of February 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,822.47, is a Delivery Order for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, identified as SPE2DB20D3103 and SPE2DB24FL3Y6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,350.70 firm-fixed-price delivery order is for the supply of 4,562,549,294 units of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRMS5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.83 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, with a completion date of May 30, 2023.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:44 AM